Shriram Pistons & Rings Limited has informed the Exchange that Record date for the purpose of Final Dividend for Financial Year 2024-25 is 25-Jul-2025.
SHRIPISTON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 13.5 pts more than Nifty Microcap 250 and 13.7 pts more than its Auto Components & Equipments peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board approved audited (standalone and consolidated) financial results for the quarter and financial year ended March 31, 2025, with a clean (unmodified) auditor opinion. Standalone revenue from operations grew to about Rs. 3,179.5 crore (up ~7.7% YoY) and standalone profit after tax rose to Rs. 497.8 crore (up ~11.4% YoY), taking standalone EPS to Rs. 113.01 versus Rs. 101.42 in FY24. Consolidated revenue grew ~15% YoY to Rs. 3,549.8 crore with consolidated PAT at Rs. 515.6 crore and consolidated EPS of Rs. 115.02. The Board recommended a total dividend of Rs. 10 per share for FY25 (Rs. 5 interim already paid plus Rs. 5 final, i.e., 100% on face value of Rs. 10), and fixed July 25, 2025 as the record date for the final dividend, with the 61st AGM scheduled for August 1, 2025. Additionally, Mr. Shinichi Unno resigned as Independent Director, Mr. Akihiro Ozaki was appointed as new Non-Executive Independent Director, two directors were re-appointed by rotation, a new Secretarial Auditor was appointed for 5 years, and the company acquired 100% of Karna Intertech Private Limited for Rs. 5 crore, making it a wholly owned subsidiary.
Investors holding shares by the July 25, 2025 record date will be eligible for the final dividend of Rs. 5 per share (on top of the Rs. 5 interim already paid), with healthy double-digit growth in both standalone and consolidated profits supporting the higher payout. The corporate actions (acquisitions, subsidiary infusion, director changes) are largely administrative and are unlikely to cause an immediate stock reaction beyond the confirmation of strong FY25 earnings and dividend.